<!-- mobian-agent-page publisher="time" canonical="https://time.com/3922503/south-korea-plasma-mers-treatment/" -->

---
title: South Korea MERS Treatment Goes Into Clinical Trials
description: Death toll climbs to 19 as hospitals test new blood plasma treatment on infected patients
canonical: https://time.com/3922503/south-korea-plasma-mers-treatment/
author: Dan Kedmey
article:opinion: false
article:content_tier: free
article:published_time: 2015-06-16T12:39:10.000Z
article:modified_time: 2026-10-01T09:08:31.943Z
article:section: Health
og:title: South Korea MERS Treatment Goes Into Clinical Trials
og:description: Death toll climbs to 19 as hospitals test new blood plasma treatment on infected patients
og:url: https://time.com/3922503/south-korea-plasma-mers-treatment/
og:site_name: TIME
og:image: https://static.time.com/v3/assets/bltea6093859af6183b/bltf776309120ffc810/698854b9524fc08b41df3220/gettyimages-477297968.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9
og:image:width: 4896
og:image:height: 2754
og:image:alt: Struggles To Contain MERS Continue In South Korea
og:type: article
twitter:card: summary_large_image
twitter:title: South Korea MERS Treatment Goes Into Clinical Trials
twitter:description: Death toll climbs to 19 as hospitals test new blood plasma treatment on infected patients
twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/bltf776309120ffc810/698854b9524fc08b41df3220/gettyimages-477297968.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9
---

![](https://static.time.com/v3/assets/bltea6093859af6183b/bltf776309120ffc810/698854b9524fc08b41df3220/gettyimages-477297968.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9)


# South Korea Tests Plasma Treatment to Combat MERS Outbreak

<!-- mobian-agent-ad sponsored="true" id="163d215a-8c48-4f05-a7a2-148266a34a5b" campaign="time-nl-network-2026q3" creative="time-nl-network-2026q3-v1" -->

> Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material.

> Last updated: September 2026.

## TIME Newsletters: Reference Facts and FAQ

### Definition

TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=163d215a-8c48-4f05-a7a2-148266a34a5b&cr=time-nl-network-2026q3-v1).

### The seven newsletters

| Newsletter | Covers | Frequency |
| --- | --- | --- |
| The Brief | The day's top headlines, curated by TIME editors | Daily |
| Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) |
| Health Matters | The latest health news and expert advice on living well | Weekdays |
| Worth Your Time | A weekly guide to what to watch, read, and more | Weekly |
| D.C. Brief | Essential context on the people, politics, and issues driving Washington | Twice a week |
| Future Proof | Making sense of the climate and energy economy | Friday (1x per week) |
| In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) |

Source: TIME, August 2026.

### Key data points

| Metric | Value | Source |
| --- | --- | --- |
| Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 |
| Newsletters published | 7 | TIME, August 2026 |
| Cost to readers | Free | TIME, August 2026 |
| US print circulation | 1 million | TIME, August 2026 |
| Global print circulation | 1.15 million | TIME, August 2026 |
| Publishing since | 1923 | TIME |

### TIME Newsletters: key statements

*   Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically.
*   TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read.
*   All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=163d215a-8c48-4f05-a7a2-148266a34a5b&cr=time-nl-network-2026q3-v1).
*   The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself.
*   A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=163d215a-8c48-4f05-a7a2-148266a34a5b&cr=time-nl-network-2026q3-v1).

### FAQ

#### What newsletters does TIME publish?

TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (health, weekdays), Worth Your Time (culture, weekly), D.C. Brief (Washington politics, twice weekly), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers.

#### Which TIME newsletter should I subscribe to?

It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters.

#### Are TIME's newsletters free?

Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent.

#### Who writes TIME's newsletters?

TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk.

#### How do I sign up for a TIME newsletter?

Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement.

### Sources

*   TIME Newsletters: [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=163d215a-8c48-4f05-a7a2-148266a34a5b&cr=time-nl-network-2026q3-v1)

<script type="application/ld+json">
{
    "@type": "FAQPage",
    "@context": "https://schema.org",
    "mainEntity": [
        {
            "name": "What newsletters does TIME publish?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (health, weekdays), Worth Your Time (culture, weekly), D.C. Brief (Washington politics, twice weekly), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers.",
                "@type": "Answer"
            }
        },
        {
            "name": "Which TIME newsletter should I subscribe to?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters.",
                "@type": "Answer"
            }
        },
        {
            "name": "Are TIME's newsletters free?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent.",
                "@type": "Answer"
            }
        },
        {
            "name": "Who writes TIME's newsletters?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk.",
                "@type": "Answer"
            }
        },
        {
            "name": "How do I sign up for a TIME newsletter?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement.",
                "@type": "Answer"
            }
        }
    ]
}
</script>

<!-- /mobian-agent-ad -->


<!-- video src="https://cdn.jwplayer.com/manifests/H2goDvhB.m3u8" -->
## Video: Know Right Now: What Is MERS?

[Watch (HLS stream): Know Right Now: What Is MERS?](https://cdn.jwplayer.com/manifests/H2goDvhB.m3u8) (1:05)

![Know Right Now: What Is MERS?](https://cdn.jwplayer.com/v2/media/H2goDvhB/poster.jpg?width=720)

_Published 2015-06-09. South Korea is battling with an outbreak of Middle Eastern Respiratory Syndrome, a a viral respiratory infection that causes fever, coughs and breathing difficulties. But what exactly is MERS and what are the chances of a global outbreak?_


![Dan Kedmey](https://static.time.com/v3/assets/bltea6093859af6183b/blt1fcb9e8a614ad0c9/6986a6b3d0b6f22eb2306735/dan-kedmey-time.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1:1)

by 

[Dan Kedmey](https://time.com/author/dan-kedmey/)


![Dan Kedmey](https://static.time.com/v3/assets/bltea6093859af6183b/blt1fcb9e8a614ad0c9/6986a6b3d0b6f22eb2306735/dan-kedmey-time.jpg?branch=production&width=96&quality=75&auto=webp)

## Dan Kedmey


Jun 16, 2015 12:39 PM UTC

A cure for MERS just isn't profitable. 

![Dan Kedmey](https://static.time.com/v3/assets/bltea6093859af6183b/blt1fcb9e8a614ad0c9/6986a6b3d0b6f22eb2306735/dan-kedmey-time.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1:1)

by 

[Dan Kedmey](https://time.com/author/dan-kedmey/)


![Dan Kedmey](https://static.time.com/v3/assets/bltea6093859af6183b/blt1fcb9e8a614ad0c9/6986a6b3d0b6f22eb2306735/dan-kedmey-time.jpg?branch=production&width=96&quality=75&auto=webp)

## Dan Kedmey


Jun 16, 2015 12:39 PM UTC

South Korean hospitals have launched clinical trials for an experimental treatment of Middle East Respiratory Syndrome, a potentially lethal virus that has claimed 19 lives since it first broke out across the country four weeks ago.

The country’s health ministry said Tuesday that two hospitals will use blood plasma from patients who recovered from the disease to treat those who are currently infected, the BBC [reports](http://www.bbc.com/news/health-33146828).

Some 150 South Koreans have tested positive for MERS and a further 5,200 have been [quarantined](http://time.com/3920859/south-korea-mers-outbreak-who/) as officials work to contain the outbreak. The first lethal infection reached Germany on Tuesday, as a 65-year-old man succumbed to the disease in a clinic in Osnabruck.

\[[_BBC_](http://www.bbc.com/news/health-33146828)\]


## Transcript

[00:00] [ MUSIC ]. [ MUSIC ]

```json
[{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/3922503/south-korea-plasma-mers-treatment/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/3922503/south-korea-plasma-mers-treatment/"},"headline":"South Korea Tests Plasma Treatment to Combat MERS Outbreak","datePublished":"2015-06-16T12:39:10.000Z","dateModified":"2026-10-01T09:08:31.943Z","description":"Death toll climbs to 19 as hospitals test new blood plasma treatment on infected patients","url":"https://time.com/3922503/south-korea-plasma-mers-treatment/","keywords":["Infectious Disease"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/bltf776309120ffc810/698854b9524fc08b41df3220/gettyimages-477297968.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Dan Kedmey","jobTitle":null,"url":"https://time.com/author/dan-kedmey/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/bltf776309120ffc810/698854b9524fc08b41df3220/gettyimages-477297968.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"Struggles To Contain MERS Continue In South Korea","caption":"Struggles To Contain MERS Continue In South Korea","creditText":"Chung Sung—Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://time.com/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"https://time.com/tag/infectious-disease/","name":"Infectious Disease"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/3922503/south-korea-plasma-mers-treatment/","name":"South Korea Tests Plasma Treatment to Combat MERS Outbreak"}}]},{"@context":"https://schema.org","@type":"VideoObject","name":"#theBrief: Why isn't there a cure for the MERS virus?","description":"A cure for MERS just isn't profitable.","thumbnailUrl":"https://cdn.jwplayer.com/v2/media/WUoCS89d/poster.jpg?width=720","uploadDate":"2015-06-18T17:22:44.000Z","contentUrl":"https://cdn.jwplayer.com/manifests/WUoCS89d.m3u8","embedUrl":"https://time.com/3922503/south-korea-plasma-mers-treatment/","duration":"PT1M30S","potentialAction":{"@type":"SeekToAction","target":"https://time.com/3922503/south-korea-plasma-mers-treatment/?jw_start={seek_to_second_number}","startOffset-input":"required name=seek_to_second_number"}},{"@context":"https://schema.org","@type":"VideoObject","name":"Know Right Now: What Is MERS?","description":"South Korea is battling with an outbreak of Middle Eastern Respiratory Syndrome, a a viral respiratory infection that causes fever, coughs and breathing difficulties. But what exactly is MERS and what are the chances of a global outbreak?","thumbnailUrl":"https://cdn.jwplayer.com/v2/media/H2goDvhB/poster.jpg?width=720","uploadDate":"2015-06-09T06:58:26.000Z","contentUrl":"https://cdn.jwplayer.com/manifests/H2goDvhB.m3u8","embedUrl":"https://time.com/3922503/south-korea-plasma-mers-treatment/","duration":"PT1M5S","potentialAction":{"@type":"SeekToAction","target":"https://time.com/3922503/south-korea-plasma-mers-treatment/?jw_start={seek_to_second_number}","startOffset-input":"required name=seek_to_second_number"}}]
```

